Results 151 to 160 of about 6,439 (198)

Economic cost of Hansen's disease: an overview of social security expenditures. [PDF]

Front Public Health
Castro JM, Rocha Lima F, Cipriani Frade MA, Souza Passador C.   +3 more
europepmc   +1 more source

Uncommon Presentation of Lepromatous Leprosy in a Nonendemic Setting: A Case Report. [PDF]

Case Rep Med
Osman ME, Alharby TN, Alhabeeb Y, Elshenawy A, Alreshidi HG, Saja Saleem Alhayeti SS, Alshammari AA.   +6 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Isoniazid in lepromatous leprosy

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1954
Abstract 1. (1) Isoniazid was given a 6-months trial in eight patients suffering from lepromatous leprosy, some of whom had responded very poorly to previous sulphone treatment. 2. (2) Some form of lepra reaction occurred in all cases, causing treatment to be temporarily interrupted in two instances and dosage to be limited in two others. 3.
W H, JOPLING, D S, RIDLEY
openaire   +2 more sources

Experimental Lepromatous Leprosy

Nature, 1967
Injection of Mycobacterium leprae has produced leprosy in mice previously thymectomized and given 900 r. of whole body irradiation to depress their immunological capacity.
R J, Rees, M F, Waters, A G, Weddell, E, Palmer   +3 more
openaire   +2 more sources

Defective production of monocyte-activating cytokines in lepromatous leprosy.

Journal of Experimental Medicine, 1984
We have examined the capacity of monocytes from patients with leprosy to undergo activation and the capacity of mononuclear cells from these patients to incorporate [3H]thymidine and produce monocyte-activating cytokines.
Marcus A Horwitz, W R Levis, Z A Cohn
exaly   +2 more sources

Relapses in lepromatous leprosy

Transactions of the Royal Society of Tropical Medicine and Hygiene, 1956
Abstract 1. (1) West African lepromatous patients whom modern treatment has rendered bacteriologically negative are liable to develop relapses in the form of fresh outcrops of macules even in spite of continued treatment. 2. (2) These relapses show clinical and histopathological characteristics of the dimorphous (indeterminate) form of ...
openaire   +2 more sources

Leonine Facies of Lepromatous Leprosy

JAMA Dermatology, 2023
This case report describes a man in his 30s presenting with a 3-year history of progressive nodules on his face and forearms and blurry vision in his left eye.
Sneha, Poondru, Victoria, Shi, Anand, Rajpara   +2 more
openaire   +2 more sources

Lepromatous Leprosy

New England Journal of Medicine, 2022
Shekhar, Neema, Santosh, Battula
openaire   +4 more sources

The HLA Association of Lepromatous Leprosy and Borderline Lepromatous Leprosy in Turkey

International Journal of Dermatology, 1988
ABSTRACT: Among 50 patients with lepromatous leprosy and borderline lepromatous leprosy in Turkey, the prevalence of HLA‐DR2 was 25/50 (50%). The prevalence of the same alleles among 50 healthy controls was 13/50 (26%).
MAT, MC, YAZICI, H, OZBAKIR, F, TUZUN, Y
openaire   +2 more sources

Mononeuritis Multiplex in Lepromatous Leprosy

Archives of Neurology, 1968
MONONEURITIS multiplex refers to involvement of several or many peripheral nerves at the same or different points in time by a disease process. It is usually asymmetric, particularly in early stages, and has been reported to occur in periarteritis nodosa, 1 diabetes mellitus, 2 and leprosy.
R N, Rosenberg, R E, Lovelace
openaire   +3 more sources